Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,981 | 203 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $927.06 | 42 | $0 (2024) |
| PFIZER INC. | $546.50 | 25 | $0 (2024) |
| UCB, Inc. | $453.87 | 13 | $0 (2024) |
| Biogen, Inc. | $354.54 | 14 | $0 (2024) |
| Eisai Inc. | $255.46 | 11 | $0 (2024) |
| Lilly USA, LLC | $201.67 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $192.89 | 9 | $0 (2024) |
| Celgene Corporation | $173.78 | 6 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $164.92 | 7 | $0 (2024) |
| SK Life Science, Inc. | $136.48 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,288 | 176 | ABBVIE INC. ($898.22) |
| 2023 | $651.65 | 25 | UCB, Inc. ($122.05) |
| 2021 | $41.06 | 2 | Biogen, Inc. ($23.19) |
All Payment Transactions
203 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | Cash or cash equivalent | $31.31 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.22 | General |
| Category: Neuroscience | ||||||
| 12/08/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Neurology | ||||||
| 12/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.22 | General |
| Category: PAIN | ||||||
| 12/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | Biogen, Inc. | AVONEX (Biological), TYSABRI, VUMERITY | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Neurology | ||||||
| 12/03/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.99 | General |
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: AMANTADINE | ||||||
| 12/02/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: Immunology | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: PAIN | ||||||
| 11/25/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.32 | General |
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: PAIN | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: PAIN | ||||||
| 11/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | InSightec,Inc | Exablate (Device) | Food and Beverage | Cash or cash equivalent | $37.84 | General |
| Category: Neurology | ||||||
| 11/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: Neurology | ||||||
| 11/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $31.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 314 | 343 | $179,619 | $39,888 |
| 2022 | 7 | 377 | 412 | $234,446 | $57,375 |
| 2021 | 6 | 132 | 134 | $82,290 | $21,525 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 45 | 45 | $33,390 | $8,384 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 73 | $31,929 | $7,276 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 78 | $29,042 | $6,098 | 21.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $27,621 | $5,821 | 21.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 34 | $20,672 | $5,041 | 24.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $22,621 | $4,037 | 17.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $14,344 | $3,230 | 22.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 101 | 102 | $75,684 | $18,451 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 113 | $49,507 | $11,920 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 80 | 80 | $45,040 | $11,256 | 25.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 47 | $28,933 | $6,884 | 23.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 39 | 40 | $26,000 | $6,658 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 18 | $5,562 | $1,313 | 23.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 12 | 12 | $3,720 | $893.46 | 24.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 59 | 59 | $43,778 | $11,418 | 26.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $10,697 | $2,851 | 26.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 15 | $9,120 | $2,270 | 24.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $7,800 | $2,080 | 26.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 15 | $6,555 | $1,749 | 26.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 12 | 14 | $4,340 | $1,157 | 26.7% |
About Ting Wu
Ting Wu is a Neurology healthcare provider based in Concord, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1730594243.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ting Wu has received a total of $4,981 in payments from pharmaceutical and medical device companies, with $4,288 received in 2024. These payments were reported across 203 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,981).
As a Medicare-enrolled provider, Wu has provided services to 823 Medicare beneficiaries, totaling 889 services with total Medicare billing of $118,787. Data is available for 3 years (2021–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Concord, MA
- Active Since 06/23/2014
- Last Updated 08/05/2021
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1730594243
Products in Payments
- NURTEC ODT (Drug) $474.01
- QULIPTA (Drug) $382.21
- BOTOX (Biological) $331.26
- Leqembi (Drug) $255.46
- Briviact (Drug) $242.97
- UBRELVY (Drug) $213.59
- REXULTI (Drug) $213.22
- AVONEX (Biological) $199.56
- ZEPOSIA (Drug) $173.78
- NUPLAZID (Drug) $164.92
- Nourianz (Drug) $124.72
- Rystiggo (Drug) $123.94
- ULTOMIRIS (Biological) $122.72
- AMYVID (Drug) $122.10
- Ocrevus (Biological) $105.13
- BRIUMVI (Drug) $94.46
- Austedo XR (Drug) $83.97
- INGREZZA (Drug) $78.46
- TYSABRI (Biological) $73.14
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $72.49
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Concord
Howard Kreger, Md, MD
Neurology — Payments: $38,473
Dr. Chad Meshberger, Do, DO
Neurology — Payments: $12,060
Russ Bodner, Md, MD
Neurology — Payments: $6,703
Dr. Daniel Garber, M.d, M.D
Neurology — Payments: $6,244
Adrian Hadiono, Md, MD
Neurology — Payments: $2,379
Russell Butler, M.d, M.D
Neurology — Payments: $1,983